Synthetic Particulate Subunit Vaccines Co‐Delivering Multiple Antigens Induce Protective Immunity Against Melioidosis
Open Access
- 10 October 2026
- journal article
- research article
- Published by Wiley in Advanced NanoBiomed Research
- p. e70162
Abstract
Melioidosis, caused by Burkholderia pseudomallei , is a life‐threatening disease and a potential biological warfare agent. Currently, no licensed vaccine is available for prevention. To address this unmet need, we bioengineered an endotoxin‐free Escherichia coli strain to assemble biopolymer inclusions coated with B. pseudomallei vaccine candidate antigens such as LolC, Omp85, OmpW, TssM, BopA, BimA, Hcp 1, Hcp 2, Hcp 3, and Hcp 6. These biopolymer particle (BP)‐based vaccines were formulated with the safe poly(I:C) adjuvant for intramuscular and intranasal administration in BALB/c mice. The vaccines were safe and induced specific and strong antibody responses. Additionally, the vaccines mediated secretion of Th1 and Th2 cytokines. No significant weight changes were observed in vaccinated groups compared with controls. In animal trials, immunized mice were challenged with a lethal dose of B. pseudomallei strain K96243 via the intraperitoneal route. Mice receiving BimA‐BP‐BopA and COM1 (a combination of BimA‐BP‐BopA, LolC‐BP‐Hcp1, and ME‐BM‐BP‐83 vaccine candidates) survived the challenge, with reduced bacterial burden in their livers and lungs when compared with empty BPs.Keywords
This publication has 85 references indexed in Scilit:
- The Th1/Th2 paradigm: A misrepresentation of helper T cell plasticityImmunology Letters, 2024
- A review on production of polyhydroxyalkanoate (PHA) biopolyesters by thermophilic microbes using waste feedstocksBioresource Technology, 2021
- Polymeric nanoparticle vaccines to combat emerging and pandemic threatsBiomaterials, 2021
- The Surprising Story of IL-2The American Journal of Pathology, 2020
- Self-assembled particulate PsaA as vaccine against Streptococcus pneumoniae infectionHeliyon, 2017
- Immunogencity of antigens from Mycobacterium tuberculosis self-assembled as particulate vaccinesInternational Journal of Medical Microbiology, 2016
- Adjuvant-enhanced CD4 T Cell Responses are Critical to Durable Vaccine ImmunityEBioMedicine, 2016
- Evaluation of a biodegradable microparticulate polymer as a carrier for Burkholderia pseudomallei subunit vaccines in a mouse model of melioidosisInternational Journal of Pharmaceutics, 2015
- Particulate vaccines: on the quest for optimal delivery and immune responseDrug Discovery Today, 2011
- Role of Vector in Activation of T Cell Subsets in Immune Responses against the Secreted Transgene Product Factor IXMolecular Therapy, 2000